Filter by
Selections
November 26, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming December 2019 Conferences
Read MoreNovember 18, 2019
Arrowhead Presents New Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at AHA Scientific Sessions 2019
Read MoreNovember 8, 2019
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019
Read MoreOctober 31, 2019
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ENaC at the North American Cystic Fibrosis Conference
Read MoreOctober 18, 2019
Arrowhead Pharmaceuticals Hosts R&D Day on Emerging Pipeline of RNAi Therapeutics
Read MoreOctober 2, 2019